Featured Post

IU researchers find new drug to prevent progression to vision loss safe and effective for people with diabetes

More than 37 million adults in the United States have diabetes, and many of them don’t even know they have it, according to the U.S. Centers for Disease Control and Prevention.

Christina Griffiths  |  Feb 07, 2023

Read this story

December Research Awards

December Research Awards

IU School of Medicine  |  Jan 25, 2023

person at computer with research graphics

New NIH data management and sharing policy effective Jan. 25

The National Institutes of Health’s Data Management and Sharing (DMS) policy becomes effective today, Jan. 25. This means all NIH grant applications and renewals that

IU School of Medicine  |  Jan 25, 2023

New High-Impact Research in Infectious Diseases

Two recent publications by faculty leaders David Aronoff, MD, and Samir Gupta, MD, exemplify the division's impact and productivity. 

Hannah Calkins  |  Jan 06, 2023

November Research Awards

November Research Awards

IU School of Medicine  |  Dec 13, 2022

Diabetes researchers Emily Sims, MD, and Anisha Gohil, DO, in the lab

IU diabetes center produces big-impact research

IU diabetes researchers are part of an international team celebrating FDA approval of the first immunotherapy drug to delay the onset of Type 1 diabetes.

Laura Gates  |  Nov 23, 2022

October Research Awards

October Research Awards

IU School of Medicine  |  Nov 15, 2022

Young cancer survivors

Researchers secure grant to better understand barriers to cancer survivorship for adolescents and young adults

A team of researchers at IU School of Medicine have received $100,000 in pilot funding to research how best to deliver cancer survivorship healthcare to

Anna Carrera  |  Nov 03, 2022

Women in Leadership, Brownsyne Tucker Edmonds

Tucker Edmonds takes on systemic issues impacting health equity

Brownsyne Tucker Edmonds, MD, MPH, MS, recently stepped into a schoolwide leadership role as IU School of Medicine’s first associate dean for health equity research,

Laura Gates  |  Oct 28, 2022